{"canonical":"https://abierto.us/vendors/xequel-bio-inc-t4jkc8b27pj7","key":"T4JKC8B27PJ7","name":"XEQUEL BIO, INC.","uei":"T4JKC8B27PJ7","city":"MOUNT PLEASANT","state":"SC","awards":2,"obligated":"-413847.54","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"4GLF5","parent_name":"XEQUEL BIO, INC.","also_known_as":[],"country":"USA","actions":4,"first_action":"2024-09-20","last_action":"2026-08-20","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"136152.46"},{"key":"541711","name":null,"awards":1,"obligated":"-550000.00"}],"places":[{"key":"SC","name":null,"awards":2,"obligated":"-413847.54"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":1,"obligated":"136152.46"},{"key":"2100","name":"Department of the Army","awards":1,"obligated":"-550000.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"-550000.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"-413847.54"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":1,"obligated":"136152.46"},{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"-550000.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":1,"obligated":"136152.46"},{"key":"AN91","name":null,"awards":1,"obligated":"-550000.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N93021C00009_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93021C00009_7529_-NONE-_-NONE-/","piid":"75N93021C00009","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"T4JKC8B27PJ7","recipient_name":"XEQUEL BIO, INC.","recipient_uei":"T4JKC8B27PJ7","recipient_cage":"4GLF5","recipient_city":"MOUNT PLEASANT","recipient_state":"SC","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-09-20","last_action_date":"2026-08-20","actions":3,"obligated":"136152.46","current_total_value":"6618886.46","potential_total_value":"6618886.46","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":5,"description":"GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_W81XWH17C0065_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_W81XWH17C0065_9700_-NONE-_-NONE-/","piid":"W81XWH17C0065","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"T4JKC8B27PJ7","recipient_name":"XEQUEL BIO, INC.","recipient_uei":"T4JKC8B27PJ7","recipient_cage":"4GLF5","recipient_city":"MOUNT PLEASANT","recipient_state":"SC","sub_name":"Department of the Army","office_name":"W4PZ USA MED RSCH ACQUIS ACT","office_key":"o-W81XWH","first_action_date":"2025-01-16","last_action_date":"2025-01-16","actions":1,"obligated":"-550000.00","current_total_value":"999960.15","potential_total_value":"999960.15","naics":"541711","psc":"AN91","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":111,"description":"ARMY SBIR MEDICAL R&D CONTRACT FOR \"PROPOSAL A2-6647 TITLED, \"A NOVEL PEPTIDE-BASED TOPICAL THERAPEUTIC TO PROMOTE CORNEAL REGENERATION AND RESTORE CORNEAL BIOMECHANICS FOLLOWING BLAST AND BURN INJURIES\" FIRSTSTRING RESEARCH, INC HAS BEEN ACQUIRED BY XEQUEL BIO. INC.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}